Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | -4.18% | -10.42% | +7.84% |
May. 15 | Blend Labs Insider Sold Shares Worth $1,992,950, According to a Recent SEC Filing | MT |
May. 08 | (BLND) BLEND Sees Q2 Revenue Range $37.5M - $41.5M | MT |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,688 | 342.3 | 632.9 | 694 | - | - |
Enterprise Value (EV) 1 | 1,354 | 204.9 | 634.3 | 607.8 | 624.1 | 621.9 |
P/E ratio | -5.65 x | -0.44 x | -3.36 x | -9.47 x | -16.8 x | 45.8 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 7.2 x | 1.46 x | 4.04 x | 4.3 x | 3.29 x | 2.59 x |
EV / Revenue | 5.77 x | 0.87 x | 4.04 x | 3.76 x | 2.96 x | 2.32 x |
EV / EBITDA | -14.3 x | -1.38 x | -8.44 x | -27.4 x | 64.5 x | 16.7 x |
EV / FCF | -10.5 x | -1.06 x | -4.95 x | -20.8 x | -357 x | 16.5 x |
FCF Yield | -9.54% | -93.9% | -20.2% | -4.8% | -0.28% | 6.06% |
Price to Book | 2.18 x | 2.82 x | -33.1 x | 7.21 x | 7.34 x | 6.23 x |
Nbr of stocks (in thousands) | 229,906 | 237,703 | 248,199 | 252,378 | - | - |
Reference price 2 | 7.340 | 1.440 | 2.550 | 2.750 | 2.750 | 2.750 |
Announcement Date | 3/31/22 | 3/16/23 | 3/14/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | 234.5 | 235.2 | 156.8 | 161.4 | 211 | 268.2 |
EBITDA 1 | - | -94.38 | -148.5 | -75.14 | -22.2 | 9.679 | 37.23 |
EBIT 1 | - | -105 | -159.2 | -77.61 | -25.06 | 8.562 | 37.6 |
Operating Margin | - | -44.77% | -67.71% | -49.48% | -15.52% | 4.06% | 14.02% |
Earnings before Tax (EBT) 1 | - | -208 | -766.1 | -179.8 | -78.33 | -46.22 | 20.5 |
Net income 1 | -74.62 | -169.1 | -768.6 | -185.3 | -74 | -41.55 | -17.67 |
Net margin | - | -72.13% | -326.79% | -118.15% | -45.84% | -19.7% | -6.59% |
EPS 2 | -5.670 | -1.300 | -3.280 | -0.7600 | -0.2903 | -0.1635 | 0.0600 |
Free Cash Flow 1 | - | -129.2 | -192.5 | -128.2 | -29.15 | -1.748 | 37.7 |
FCF margin | - | -55.11% | -81.84% | -81.74% | -18.06% | -0.83% | 14.06% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | 101.26% |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - |
Announcement Date | 6/21/21 | 3/31/22 | 3/16/23 | 3/14/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 80.99 | 71.52 | 65.54 | 55.35 | 42.78 | 37.34 | 42.82 | 40.59 | 36.1 | 34.95 | 38.93 | 43.77 | 43.96 | 46.1 | 51.51 |
EBITDA 1 | -34.85 | -34.93 | -34.86 | -36.18 | -42.51 | -30.1 | -17.25 | -15.29 | -12.51 | -10.66 | -7.916 | -3.746 | -0.8269 | -1.89 | 1.532 |
EBIT 1 | -38.69 | -39.53 | -39.49 | -37.1 | -43.12 | -30.73 | -17.88 | -15.89 | -13.11 | -11.22 | -8.619 | -4.247 | -0.8095 | -2.06 | 1.692 |
Operating Margin | -47.77% | -55.27% | -60.25% | -67.03% | -100.79% | -82.3% | -41.76% | -39.14% | -36.32% | -32.11% | -22.14% | -9.7% | -1.84% | -4.47% | 3.29% |
Earnings before Tax (EBT) 1 | -65.42 | -75.22 | -477.1 | -132.7 | -80.97 | -66.12 | -41.44 | -41.78 | -30.45 | -20.62 | -21.92 | -18.4 | -17.4 | -9.6 | -2.3 |
Net income 1 | -71.51 | -73.55 | -478.4 | -134 | -82.71 | -67.47 | -42.82 | -43.21 | -31.81 | -22.13 | -19.99 | -16.38 | -14.91 | -10.44 | -5.74 |
Net margin | -88.3% | -102.83% | -729.92% | -242.04% | -193.32% | -180.72% | -100.02% | -106.46% | -88.11% | -63.32% | -51.35% | -37.43% | -33.93% | -22.65% | -11.14% |
EPS 2 | -0.3200 | -0.3200 | -2.060 | -0.5700 | -0.3500 | -0.2800 | -0.1800 | -0.1800 | -0.1300 | -0.0900 | -0.0780 | -0.0629 | -0.0596 | -0.0414 | -0.0222 |
Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/31/22 | 5/12/22 | 8/15/22 | 11/10/22 | 3/16/23 | 5/9/23 | 8/9/23 | 11/7/23 | 3/14/24 | 5/8/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 1.41 | - | - | - |
Net Cash position 1 | - | 333 | 137 | - | 86.3 | 69.9 | 72.2 |
Leverage (Debt/EBITDA) | - | - | - | -0.0188 x | - | - | - |
Free Cash Flow 1 | - | -129 | -192 | -128 | -29.2 | -1.75 | 37.7 |
ROE (net income / shareholders' equity) | - | -24.8% | -40.6% | - | -83.8% | 3.93% | 20.7% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | 3.360 | 0.5100 | -0.0800 | 0.3800 | 0.3700 | 0.4400 |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | - | 1.73 | 2.07 | 0.59 | 7.33 | 4.99 | 6.27 |
Capex / Sales | - | 0.74% | 0.88% | 0.37% | 4.54% | 2.37% | 2.34% |
Announcement Date | 6/21/21 | 3/31/22 | 3/16/23 | 3/14/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.84% | 694M | |
+8.91% | 85.92B | |
+5.14% | 77.93B | |
-16.20% | 52.89B | |
+26.18% | 48.28B | |
+28.93% | 45.38B | |
-34.05% | 40.83B | |
+66.72% | 38.78B | |
-0.36% | 27.48B | |
-26.47% | 21.52B |
- Stock Market
- Equities
- BLND Stock
- Financials Blend Labs, Inc.